248 related articles for article (PubMed ID: 9228472)
1. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Phillips P; Shafran S; Garber G; Rotstein C; Smaill F; Fong I; Salit I; Miller M; Williams K; Conly JM; Singer J; Ioannou S
Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):337-45. PubMed ID: 9228472
[TBL] [Abstract][Full Text] [Related]
2. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
Rex JH; Bennett JE; Sugar AM; Pappas PG; van der Horst CM; Edwards JE; Washburn RG; Scheld WM; Karchmer AW; Dine AP
N Engl J Med; 1994 Nov; 331(20):1325-30. PubMed ID: 7935701
[TBL] [Abstract][Full Text] [Related]
4. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
6. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Dranitsaris G; Phillips P; Rotstein C; Puodziunas A; Shafran S; Garber G; Smaill F; Salit I; Miller M; Williams K; Conly J; Singer J; Ioannou S
Pharmacoeconomics; 1998 May; 13(5 Pt 1):509-18. PubMed ID: 10180750
[TBL] [Abstract][Full Text] [Related]
9. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
13. Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.
Kontoyiannis DP; Bodey GP; Mantzoros CS
Mycoses; 2001; 44(5):125-35. PubMed ID: 11486448
[TBL] [Abstract][Full Text] [Related]
14. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
[TBL] [Abstract][Full Text] [Related]
17. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Pappas PG; Rex JH; Lee J; Hamill RJ; Larsen RA; Powderly W; Kauffman CA; Hyslop N; Mangino JE; Chapman S; Horowitz HW; Edwards JE; Dismukes WE;
Clin Infect Dis; 2003 Sep; 37(5):634-43. PubMed ID: 12942393
[TBL] [Abstract][Full Text] [Related]
18. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
19. Anidulafungin versus fluconazole for invasive candidiasis.
Reboli AC; Rotstein C; Pappas PG; Chapman SW; Kett DH; Kumar D; Betts R; Wible M; Goldstein BP; Schranz J; Krause DS; Walsh TJ;
N Engl J Med; 2007 Jun; 356(24):2472-82. PubMed ID: 17568028
[TBL] [Abstract][Full Text] [Related]
20. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
Torres HA; Kontoyiannis DP; Rolston KV
Support Care Cancer; 2004 Jul; 12(7):511-6. PubMed ID: 14986077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
